These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 22003835)

  • 21. Combination of local, non-viral IL12 gene therapy and systemic paclitaxel chemotherapy in a syngeneic ID8 mouse model for human ovarian cancer.
    Janát-Amsbury MM; Yockman JW; Anderson ML; Kieback DG; Kim SW
    Anticancer Res; 2006; 26(5A):3223-8. PubMed ID: 17094433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma.
    Sangaletti S; Stoppacciaro A; Guiducci C; Torrisi MR; Colombo MP
    J Exp Med; 2003 Nov; 198(10):1475-85. PubMed ID: 14610043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The matricellular protein SPARC supports follicular dendritic cell networking toward Th17 responses.
    Piconese S; Costanza M; Tripodo C; Sangaletti S; Musio S; Pittoni P; Poliani PL; Burocchi A; Passafaro AL; Gorzanelli A; Vitali C; Chiodoni C; Barnaba V; Pedotti R; Colombo MP
    J Autoimmun; 2011 Dec; 37(4):300-10. PubMed ID: 21962567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.
    Arnold SA; Rivera LB; Miller AF; Carbon JG; Dineen SP; Xie Y; Castrillon DH; Sage EH; Puolakkainen P; Bradshaw AD; Brekken RA
    Dis Model Mech; 2010; 3(1-2):57-72. PubMed ID: 20007485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preconditioned endothelial progenitor cells reduce formation of melanoma metastases through SPARC-driven cell-cell interactions and endocytosis.
    Defresne F; Bouzin C; Grandjean M; Dieu M; Raes M; Hatzopoulos AK; Kupatt C; Feron O
    Cancer Res; 2011 Jul; 71(14):4748-57. PubMed ID: 21616936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host.
    Podhajcer OL; Benedetti LG; Girotti MR; Prada F; Salvatierra E; Llera AS
    Cancer Metastasis Rev; 2008 Dec; 27(4):691-705. PubMed ID: 18542844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of a liver metastatic model of human ovarian cancer.
    Yoshida Y; Kamitani N; Sasaki H; Kusumi K; Tominaga T; Kotsuji F
    Anticancer Res; 1998; 18(1A):327-31. PubMed ID: 9568098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength.
    Bradshaw AD; Puolakkainen P; Dasgupta J; Davidson JM; Wight TN; Helene Sage E
    J Invest Dermatol; 2003 Jun; 120(6):949-55. PubMed ID: 12787119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC.
    John B; Naczki C; Patel C; Ghoneum A; Qasem S; Salih Z; Said N
    Oncogene; 2019 May; 38(22):4366-4383. PubMed ID: 30765860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation.
    Arnold SA; Rivera LB; Carbon JG; Toombs JE; Chang CL; Bradshaw AD; Brekken RA
    PLoS One; 2012; 7(2):e31384. PubMed ID: 22348081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splenic and immune alterations of the Sparc-null mouse accompany a lack of immune response.
    Rempel SA; Hawley RC; Gutiérrez JA; Mouzon E; Bobbitt KR; Lemke N; Schultz CR; Schultz LR; Golembieski W; Koblinski J; VanOsdol S; Miller CG
    Genes Immun; 2007 Apr; 8(3):262-74. PubMed ID: 17344888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78.
    Mo L; Bachelder RE; Kennedy M; Chen PH; Chi JT; Berchuck A; Cianciolo G; Pizzo SV
    Mol Cancer Ther; 2015 Mar; 14(3):747-56. PubMed ID: 25589495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Orthotopic Mouse Model of Ovarian Cancer using Human Stroma to Promote Metastasis.
    Atiya HI; Orellana TJ; Wield A; Frisbie L; Coffman LG
    J Vis Exp; 2021 Mar; (169):. PubMed ID: 33843939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target.
    Feng J; Tang L
    Curr Pharm Des; 2014; 20(39):6182-90. PubMed ID: 24947586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Transabdominal Ultrasound for the detection of intra-peritoneal tumor engraftment and growth in mouse xenografts of epithelial ovarian cancer.
    Chambers LM; Esakov E; Braley C; AlHilli M; Michener C; Reizes O
    PLoS One; 2020; 15(4):e0228511. PubMed ID: 32348309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthy and tumoral tissue resistivity in wild-type and sparc-/- animal models.
    Meroni D; Mauri G; Bovio D; Bianchi AM; Chiodoni C; Colombo MP; Meroni E; Aliverti A
    Med Biol Eng Comput; 2016 Dec; 54(12):1949-1957. PubMed ID: 27099155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel early-stage orthotopic model for ovarian cancer in the Fischer 344 rat.
    Sloan Stakleff KD; Rouse AG; Ryan AP; Haller NA; Von Gruenigen VE
    Int J Gynecol Cancer; 2005; 15(2):246-54. PubMed ID: 15823107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in gene expression profiles from asbestos-treated SPARC-null and wild-type mouse lungs.
    Pershouse MA; Smartt AM; Schwanke C; Putnam EA
    Genomics; 2009 Aug; 94(2):101-9. PubMed ID: 19446018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancer.
    Liao JB; Ovenell KJ; Curtis EE; Cecil DL; Koehnlein MR; Rastetter LR; Gad EA; Disis ML
    J Immunother Cancer; 2015; 3():16. PubMed ID: 25992288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer.
    Cook DP; Galpin KJC; Rodriguez GM; Shakfa N; Wilson-Sanchez J; Echaibi M; Pereira M; Matuszewska K; Haagsma J; Murshed H; Cudmore AO; MacDonald E; Tone A; Shepherd TG; Petrik JJ; Koti M; Vanderhyden BC
    Commun Biol; 2023 Nov; 6(1):1152. PubMed ID: 37957414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.